Delcath Systems Inc (DCTH)

[Simsim99]

Sure the price could have been higher. But at the end of the day they got money they needed and unlike the convertible the purchasers have zero incentive to push the price lower now. And even at 1 billion shares assuming warrant conversion the stock is cheap at $30 million market cap assuming warrant conversion.
For me the question is would I invest in a company well into phase 3 for a deadly cancer treatment with no effective treatment that already has shown it’s effectiveness both in Europe and in a previous phase 3. For me the answer is yes and I added more at .02839. The stock in my opinion is too cheap.